secwatch.observer — SEC 8-K summary
======================================

Issuer:     Propanc Biopharma, Inc. (PPCB)
CIK:        0001517681
Form:       8-K
Filed at:   2025-08-19T23:59:59+00:00
Accession:  0001641172-25-024872
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Propanc Biopharma prices $4M public offering, uplists to Nasdaq; appoints two independent directors
--------------------------------------------------------------------------------

- Raised $4M gross ($3.34M net) via public offering of 1M shares at $4.00/sh; underwriters have 45-day option for 150K more.
- Common stock began trading on Nasdaq Capital Market on Aug 15 under symbol PPCB, uplisted from OTC Pink.
- Appointed Joseph Himy and Annie VanBroekhoven as independent directors on Aug 14; serving on audit, compensation, nominating committees.
- Issued Representative's warrants to D. Boral Capital for 30,000 shares at $4.00, exercisable from Feb 2026 to Aug 2030.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1517681/000164117225024872/0001641172-25-024872-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1517681/000164117225024872/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-024872

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer